(Total Views: 395)
Posted On: 08/08/2022 1:21:07 PM
Post# of 246
$RSHN heliosDX Responds To Growing Concerns About Monkeypox By Adding Testing To Its Infectious Disease Panel
https://www.accesswire.com/711242/heliosdx-re...ease-panel
ALPHARETTA, GA / ACCESSWIRE / August 8, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company"
is pleased to announce that heliosDX is expanding its Infectious Disease PCR panel to include the Human Monkeypox Virus.
Due to the rising concern and surge of reported cases of the Monkeypox Virus in the United States, heliosDX is adding testing to its infectious disease panel immediately. Together with our lab partners we are responding to the growing need of testing to identify the virus accurately and in turn to allow physicians and clinics nationwide to effectively treat patients that are suffering. We expect to have testing readily available in 24 to 48 hours. More information to follow in the coming days.
https://www.accesswire.com/711242/heliosdx-re...ease-panel
ALPHARETTA, GA / ACCESSWIRE / August 8, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company"
is pleased to announce that heliosDX is expanding its Infectious Disease PCR panel to include the Human Monkeypox Virus. Due to the rising concern and surge of reported cases of the Monkeypox Virus in the United States, heliosDX is adding testing to its infectious disease panel immediately. Together with our lab partners we are responding to the growing need of testing to identify the virus accurately and in turn to allow physicians and clinics nationwide to effectively treat patients that are suffering. We expect to have testing readily available in 24 to 48 hours. More information to follow in the coming days.
(1)
(0)
